Mustang Bio Inc (MBIO)
0.3701
-0.01
(-3.62%)
USD |
NASDAQ |
Apr 18, 16:00
0.3898
+0.02
(+5.32%)
Pre-Market: 09:13
Mustang Bio Cash from Financing (TTM): -26.08M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -26.08M |
September 30, 2023 | -30.04M |
June 30, 2023 | -29.49M |
March 31, 2023 | 3.835M |
December 31, 2022 | 34.06M |
September 30, 2022 | 38.97M |
June 30, 2022 | 41.41M |
March 31, 2022 | 53.46M |
December 31, 2021 | 70.85M |
September 30, 2021 | 99.42M |
June 30, 2021 | 97.81M |
March 31, 2021 | 120.65M |
December 31, 2020 | 78.12M |
September 30, 2020 | 44.63M |
June 30, 2020 | 42.90M |
Date | Value |
---|---|
March 31, 2020 | 56.58M |
December 31, 2019 | 65.12M |
September 30, 2019 | 65.12M |
June 30, 2019 | 65.23M |
March 31, 2019 | 13.70M |
December 31, 2018 | 0.181M |
September 30, 2018 | 0.181M |
June 30, 2018 | 0.243M |
March 31, 2018 | 0.15M |
December 31, 2017 | 49.98M |
September 30, 2017 | 68.62M |
June 30, 2017 | 80.24M |
March 31, 2017 | 80.97M |
December 31, 2016 | 31.63M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-30.04M
Minimum
Sep 2023
120.65M
Maximum
Mar 2021
46.98M
Average
53.46M
Median
Mar 2022
Cash from Financing (TTM) Benchmarks
Avinger Inc | 5.112M |
Fortress Biotech Inc | 32.74M |
AIM ImmunoTech Inc | 0.485M |
Protalix BioTherapeutics Inc | 24.67M |
Armata Pharmaceuticals Inc | 53.99M |